{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-25-000131","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.761324+00:00","generated_at":"2026-05-21T04:34:53.851814+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Globus Medical authorizes $500M share repurchase program","bullets":["Board authorized up to $500M buyback of Class A common stock.","CFO cites disconnect between intrinsic value and market valuation.","Repurchases at management's discretion; no time limit, can be suspended.","Funding from cash reserves; program aligns with capital allocation strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-25-000131","json":"https://secwatch.observer/filing/0001562762-25-000131.json","markdown":"https://secwatch.observer/filing/0001562762-25-000131.md","text":"https://secwatch.observer/filing/0001562762-25-000131.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000156276225000131/0001562762-25-000131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000156276225000131/gmed-20250515x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T04:34:53.851814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}